&nbsp;

Nov 2025

Drug

siltuximab

Other Name(s): Sylvant®

Quick Link(s):

Mar 2025

Drug

palbociclib

Other Name(s): Ibrance™

Quick Link(s):

Oct 2025

Drug

osimertinib

Other Name(s): Tagrisso®

Quick Link(s):

Nov 2025

Drug

venetoclax

Other Name(s): Venclexta®

Quick Link(s):

Aug 2025

Drug

alectinib

Other Name(s): Alecensaro®

Quick Link(s):

Nov 2025

Drug

atezolizumab

Other Name(s): Tecentriq™

Quick Link(s):

Jul 2025

Drug

midostaurin

Other Name(s): Rydapt®

Quick Link(s):

Jun 2025

Drug

liposomal irinotecan

Other Name(s): Onivyde® (Baxalta Canada)

Quick Link(s):

Sep 2017

Regimen

CISPFU(RT)

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

, Collapse Show fewer tags

Intent: Adjuvant, Palliative

Drugs Used:

CISplatin,

fluorouracil

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2017

Regimen

DASA

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

daSAtinib - Ph+ CML in the chronic phase, with specific criteria

Exceptional Access Program

daSAtinib - Accelerated phase or blast phase Ph+ CML with documented resistance or intolerance to imatinib, with specific criteria

, Collapse Show fewer tags

Drugs Used:

daSATinib

... Show more tags

Quick Link(s):

Regimen Monograph

Feb 2025

Regimen

DCRB

Cancer Type:

Sarcoma,

Soft Tissue,

Skin,

Melanoma